肾结石内科管理:AUA指南(2026)第二部分:治疗与随访
该指南基于30篇文献的系统综述,针对有肾结石病史的非妊娠成人和儿童,提出识别高复发风险个体、代谢评估、饮食与药物治疗及随访评估疗效的推荐,旨在降低结石复发风险。
要点
- 识别结石复发高风险个体是治疗与随访的起点
- 对高风险及有意愿患者进行代谢评估
- 启动饮食措施和药物治疗以降低复发风险
核心结论
- 基于最佳证据和专家组意见,指南推荐对积极治疗的高风险患者启动饮食措施和药物治疗以降低结石复发风险。
研究设计与样本
- 指南基于RTI国际-北卡罗来纳大学教堂山分校循证实践中心受AHRQ合同资助、PCORI拨款支持的系统综述,纳入30篇文献,涵盖非妊娠成人和有肾结石病史儿童的预防治疗(饮食或药物)及监测影像策略的比较效果与危害。
主要发现
- 指南制定了一系列声明,涉及识别结石复发高风险个体、对高风险及有意愿患者进行代谢评估、饮食措施与药物治疗以及随访评估治疗效果。
关键数值与推荐
- 指南声明基于本指南的证据基础制定,具体推荐条款未在摘要中逐条列出。
临床怎么用
- 临床应识别结石复发高风险患者,对其进行代谢评估,并启动饮食措施和药物治疗以降低复发风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: The purpose of this Guideline is to provide a framework for the treatment and follow-up of patients with a history of kidney stones in order to reduce the likelihood of recurrent disease. The summary presented herein represents Part II of the two-part series dedicated to Medical Management of Kidney Stones. Please refer to Part I for additional information on this topic. MATERIALS AND METHODS: The systematic review utilized in the creation of this Guideline is based on research conducted by the Research Triangle Institute (RTI) International-University of North Carolina at Chapel Hill Evidence-based Practice Center (EPC) under contract to the Agency for Healthcare Research and Quality (AHRQ) and funded by the Patient-Centered Outcomes Research Institute (PCORI). The EPC extracted and synthesized comparative effectiveness and harms outcomes for preventive treatment with diet or pharmacologic agents and surveillance imaging strategies in nonpregnant adults and children with a history of nephrolithiasis from 30 publications. RESULTS: A series of Guideline statements were developed that addresses the identification of individuals at high-risk of stone recurrence, the metabolic evaluation of high-risk and interested patients, treatment with dietary measures and pharmacologic therapy, and follow-up for assessment of therapeutic effects. The statements were developed based on the evidence base for this Guideline. CONCLUSIONS: Using the best available evidence and the expert opinion of the Panel, this Guideline offers recommendations for the initiation of dietary measures and drug therapy to allow for active treatment of motivated and high-risk patients with the goal of reducing the risk of stone recurrence.
引用
- Pearle MS, Matlaga BR, Antonelli JA, et al. Medical Management of Kidney Stones: AUA Guideline (2026) Part II: Treatment and Follow-up of Kidney Stones. J Urol. 2026. PMID: 42529979. doi:10.1097/JU.0000000000005228
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。